Connection
Fenghuang Zhan to Risk
This is a "connection" page, showing publications Fenghuang Zhan has written about Risk.
|
|
Connection Strength |
|
|
|
|
|
0.022 |
|
|
|
-
Zangari M, Fink L, Zhan F, Tricot G. Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens. Clin Lymphoma Myeloma Leuk. 2011 Apr; 11(2):228-36.
Score: 0.022